Terms: = Kidney tumors AND BTG1, P62324, 694, ENSG00000133639
46 results:
1. Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database.
Lai GS; Li JR; Wang SS; Chen CS; Yang CK; Lin CY; Hung SC; Chiu KY; Yang SF
PLoS One; 2024; 19(3):e0299102. PubMed ID: 38547226
[TBL] [Abstract] [Full Text] [Related]
2. Oncologic outcomes of patients treated with kidney-sparing surgery or radical nephroureterectomy for upper urinary tract urothelial cancer: a population-based study.
Ślusarczyk A; Zapała P; Zapała Ł; Rajwa P; Moschini M; Laukhtina E; Radziszewski P
Urol Oncol; 2024 Jan; 42(1):22.e1-22.e11. PubMed ID: 37981503
[TBL] [Abstract] [Full Text] [Related]
3. Prediction of Fuhrman nuclear grade for clear cell renal carcinoma by a multi-information fusion model that incorporates CT-based features of tumor and serum tumor associated material.
Zhang Y; Sun Z; Ma H; Wang C; Zhang W; Liu J; Li M; Zhang Y; Guo H; Ba X
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15855-15865. PubMed ID: 37672076
[TBL] [Abstract] [Full Text] [Related]
4. Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma.
Dizman N; Govindarajan A; Zengin ZB; Meza L; Tripathi N; Sayegh N; Castro DV; Chan EH; Lee KO; Prajapati S; Feng M; Loo V; Pace M; O'Brien S; Bailey E; Barragan-Carrillo R; Chehrazi-Raffle A; Hsu J; Li X; Agarwal N; Pal SK
Clin Genitourin Cancer; 2023 Oct; 21(5):530-536. PubMed ID: 37495481
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes of Head and Neck Free Tissue Transfer in Renal Failure Patients.
Oglesby KR; Jefferson GD; Thomas CM; Tomblin C; Alnemri A; Curry JM; Bonaventure C; Sweeny L; Richards HW; Wax M; Kane AC
Laryngoscope; 2024 Feb; 134(2):688-694. PubMed ID: 37449944
[TBL] [Abstract] [Full Text] [Related]
6. Immunotherapy with Autoimmune Complication in Renal Cancer.
Sunil SP; Kumar S; Hussaini S; Kandula S
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116021
[TBL] [Abstract] [Full Text] [Related]
7. [Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma].
Qin CP; Song YX; Ding MT; Wang F; Lin JX; Yang WB; DU YQ; Li Q; Liu SJ; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):663-668. PubMed ID: 35950389
[TBL] [Abstract] [Full Text] [Related]
8. Neuron-Specific Enolase and Hemoglobin as Risk Factors of Intraocular Metastasis in Patients with Renal Cell Carcinoma.
Li QY; Su T; Shi WQ; Fang JW; Zhang MY; Xu QH; Liang RB; Ge QM; Li B; Shao Y
Dis Markers; 2022; 2022():2883029. PubMed ID: 35502301
[TBL] [Abstract] [Full Text] [Related]
9. Liver Transplant Recipients Who Survive for More Than 10 Years: A Long-Term Survey.
Ayvazoğlu Soy EH; Akdur A; Karakaya E; Moray G; Haberal M
Exp Clin Transplant; 2022 Mar; 20(Suppl 1):20-23. PubMed ID: 35384803
[TBL] [Abstract] [Full Text] [Related]
10. New predictive factors for prolonged operation time of laparoscopic posterior retroperitoneal adrenalectomy; retrospective cohort study.
Rah CS; Kim WW; Lee YM; Chung KW; Koh JM; Lee SH; Hong SJ; Sung TY
Int J Surg; 2021 Oct; 94():106113. PubMed ID: 34534705
[TBL] [Abstract] [Full Text] [Related]
11. Exposure-toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer.
Krens SD; van Boxtel W; Uijen MJM; Jansman FGA; Desar IME; Mulder SF; van Herpen CML; van Erp NP
Int J Cancer; 2022 Jan; 150(2):308-316. PubMed ID: 34494665
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
[TBL] [Abstract] [Full Text] [Related]
13. Association between bariatric surgery and risks of cancer among Chinese patients with type 2 diabetes mellitus: A retrospective cohort study.
Wei Y; Wong SKH; Wu T; Law BTT; Ng EKW; Lam CLK; Wong CKH
J Diabetes; 2021 Nov; 13(11):868-881. PubMed ID: 33728788
[TBL] [Abstract] [Full Text] [Related]
14. Clinical significance of prognostic nutritional index in renal cell carcinomas.
Tang Y; Liang J; Liu Z; Zhang R; Zou Z; Wu K; Lu Y; Wei X
Medicine (Baltimore); 2021 Mar; 100(10):e25127. PubMed ID: 33725913
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study.
Mao W; Fu Z; Wang K; Wu J; Xu B; Chen M
Ann Palliat Med; 2021 Mar; 10(3):2791-2804. PubMed ID: 33549017
[TBL] [Abstract] [Full Text] [Related]
16. Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study.
Singleton RK; Heath AK; Clasen JL; Scelo G; Johansson M; Calvez-Kelm FL; Weiderpass E; Liedberg F; Ljungberg B; Harbs J; Olsen A; Tjønneland A; Dahm CC; Kaaks R; Fortner RT; Panico S; Tagliabue G; Masala G; Tumino R; Ricceri F; Gram IT; Santiuste C; Bonet C; Rodriguez-Barranco M; Schulze MB; Bergmann MM; Travis RC; Tzoulaki I; Riboli E; Muller DC
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):507-512. PubMed ID: 33335022
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Significance of the Controlling Nutritional Status (CONUT) Score in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab after Failure of Prior Tyrosine Kinase Inhibitors.
Takemura K; Yuasa T; Fujiwara R; Ito M; Suzuki H; Yonese J; Koga F
J Urol; 2020 Dec; 204(6):1166-1172. PubMed ID: 32567459
[TBL] [Abstract] [Full Text] [Related]
18. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
[TBL] [Abstract] [Full Text] [Related]
19. Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.
Sterling J; Rivera-Núñez Z; Patel HV; Farber NJ; Kim S; Radadia KD; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Clin Genitourin Cancer; 2020 Dec; 18(6):e643-e650. PubMed ID: 32389458
[TBL] [Abstract] [Full Text] [Related]
20. Mucinous Tubular and Spindle-Cell Carcinoma of the kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes.
Ged Y; Chen YB; Knezevic A; Donoghue MTA; Carlo MI; Lee CH; Feldman DR; Patil S; Hakimi AA; Russo P; Voss MH; Motzer RJ
Clin Genitourin Cancer; 2019 Aug; 17(4):268-274.e1. PubMed ID: 31151928
[TBL] [Abstract] [Full Text] [Related]
[Next]
